Metabolomics study reveals the alteration of fatty acid oxidation in the hearts of diabetic mice by empagliflozin
Empagliflozin
DOI:
10.1039/d2mo00036a
Publication Date:
2022-04-22T06:01:29Z
AUTHORS (5)
ABSTRACT
Metabolomics screening revealed the alteration of fatty acid oxidation in hearts diabetic mice after SGLT2i treatment.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (35)
CITATIONS (10)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....